Current Events

Light sheet, super-resolution and mesolenses; microscopy techniques are evolving rapidly to meet the demands for ever higher resolution in complex systems to help understand biology and disease. To learn more about how new imaging techniques are being adopted throughout academia and industry then please come and join us at this free-to-attend ELRIG webinar followed by a short question and answer session with the speakers. << less

Light sheet, super-resolution and mesolenses; microscopy techniques are evolving rapidly to meet the demands for ever higher resolution in complex systems to help understand biology and disease. To learn more about how new imaging techniques are being adopted throughout academia and industry then please more >>

The 2020 ELRIG Research & Innovation conference will discuss how the most promising new biology is being identified and explore emerging technologies and innovations to enable this science to be translated into successful therapeutics. The four scientific sessions will address different aspects of innovation in biology and discovery technologies as we move into a new decade

24th Pharmacovigilance 2021
“Latest developments in pharmacovigilance, drug safety and RMP”
24th - 25th February 2021, Virtual Conference (Time Zone - GMT)
This conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.
DELEGATE REGISTRATION:
Email: kavitha@virtueinsight.co.in or Call: +44-20 3509 3779
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
Early Bird Pricing
1 Delegate @ £400 + VAT (Valid Till 28th January 2021)
3 Delegates @ £1000 +VAT (Valid Till 28th January 2021)
Standard Pricing
1 Delegate @ £600 +VAT (Valid From 29th January 2021)
3 Delegates @ £1400 + VAT (Valid From 29th January 2021)
Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in .
KEY SPEAKERS:
• WILLIAM WANG, Executive Director, Clinical Safety Statistics, Merck (USA)
• MICHAEL BEAN, Senior Director, Regulatory Compliance R&D, Johnson & Johnson
• WIVINA DE WAELE, Director, Regional Safety Excellence EMEA. Global Drug Safety, Alexion Pharmaceuticals
• KHAUDEJA BANO, Executive Medical Director, Combination Product Safety Head, Amgen (USA)
• SUMIT MUNJAL, Vice President, Global Patient Safety Evaluation, Takeda
• JOHN SOLOMON, Head of Pharmacovigilance - UK & Ireland, Sanofi
• OYINKANSOLA ODEBO, Assistant Director, Drug Safety Clinical Research, Supernus Pharmaceuticals (USA)
• ALESSANDRO VAGHEGGINI, Associate Principal Biostatistician, Clinical Safety Statistics, Merck (USA)
• TEA BABIC, Assoc. Dir – Audits and Inspections, Teva
• DAVID J LEWIS, EU QPPV Head QPPV Office, Novartis
• SHAUN COMFORT, Principal Scientific Enablement Director, Roche – Genentech
• YUUNG YUUNG YAP, Senior International Regulatory Counsel, EU and International Regulatory Law, Pfizer
• DAVID JEFFERYS, Sr. VP Regulatory, Eisai
• VALENTINA MANCINI, Director PV, EU QPPV, Shionogi Europe
• ROSALINA DOMIN, Senior Director, QA and Deviation Management Head, PV Quality, Sanofi
• RAJ BHOGAL, Sr. Director, R&D Audits & Inspections, Jazz Pharmaceuticals
• ANDREA OLIVA, Head of Pharmacovigilance, Mylan
• JAYLAXMI NALAWADE, Associate Director - Pharmacovigilance & REMS, Lupin
• FRANCK SCHWARTZ, QA Global Inspection, Intelligence Lead - Compliance & Regulatory Affairs Quality, Novartis
• YVONNE NANCIU, Senior Manager Pharmacovigilance & Medical Information, Local QPPV, Abbvie
• RUDI SCHEERLINCK, Global Head Pharmacovigilance Risk Management, Nestle
• CHETAN SHATAPATHY, Principal Pharamcovigilance Physician - Oncology R&D Unit, AstraZeneca
• JOHN POUSTIE, Senior Director, Global Pharmacovigilance, Norgine
• SUE REES, Pharmacovigilance Expert, (Former EU QPPV Executive Director, Global Safety), Amgen
• GAURI UTTURKAR, Senior Manager - Pharmacovigilance, Glenmark Pharmaceuticals
• LISBETH TOFTE HEMMINGSEN, Director, Drug Safety Consult
• NICOLE BAKER, Co-Founder, BioLogit
• MARY LYNNE VAN POELGEEST, President, World Federation for Incontinent Patients -(WFIP)
Plus more joining soon
FOCUSES ON:
• Overcoming this Pandemic Issues - Drug Safety Strategy for Pharmaceutical organisations
• Outsourcing in Pharmacovigilance- Best Practices, Challenges and key consideration
• Key factors driving the current global Pharmacovigilance (PV) market?
• Pharmacovigilance and assessment of drug safety reports during COVID 19
• What are the market opportunities, market risk and market overview of the (PV) market?
• PV Audit & Inspections – Keeping on the right side of Inspectors
• Documentation (RMPs, PSURs, PADERs, PBRERs)
• Practical approaches - Quality, Safety & Signal Detection
• Medical devices – Increasing safety perspective
• Improving patient safety
• New Technologies in Pharmacovigilance (AI/ Machine Learning, IoT)
• Brexit Implications for the Pharmaceutical (pharmacovigilance) Industry
• RoW - Recent developments and future perspectives
• The developing regulatory framework in advanced and developing markets – EU, USA & ROW
• Be part of a major networking opportunity
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition.


<< less

24th Pharmacovigilance 2021
“Latest developments in pharmacovigilance, drug safety and RMP”
24th - 25th February 2021, Virtual Conference (Time Zone - GMT)
This conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the more >>

9th Annual Pharma AntiCounterfeiting & Serialisation 2021
“Competences to Combat Counterfeits & Impact of AI, IoT, Blockchain & Big Data in Pharma”
03rd - 04th March 2021, Virtual Conference (Time Zone – GMT)

This conference overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems, this conference addresses serialisation, track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products.
DELEGATE REGISTRATION:
Email: kavitha@virtueinsight.co.in or Call: +44-20 3509 3779
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
Early Bird Pricing
1 Delegate @ £400 + VAT (Valid Till 05th February 2021)
3 Delegates @ £1000 +VAT (Valid Till 05th February 2021)
Standard Pricing
1 Delegate @ £550 +VAT (Valid From 06th February 2021)
3 Delegates @ £1350 + VAT (Valid From 06th February 2021)
Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in
KEY SPEAKERS:
• NICHOLAS CALL, Special Agent / Senior Operations Manager, Office of Criminal Investigations, FDA
• RORY CORCORAN, A/Assistant Director, Organized and Emerging Crime, Interpol
• EDMUND DARVIEU, VP Corporate Security, Sanofi
• ROBERT POPOVIAN, SR. Director, US Government Relations, Pfizer (USA)
• RAVI KALYANARAMAN, Director, Bristol-Myers Squibb (USA)
• SAI MUNGARA, Vice President and Head of North America Supply Chain, Sun Pharma (USA)
• EIKE HILLBRICHT, Corporate Security Manager, Boehringer Ingelheim
• ADRIAN VAN DEN HOVEN, Director General, Medicines for Europe
• JEREMY PETERS, Scientist, Bristol-Myers Squibb (USA)
• MIKE ISLES, Executive Director, European Alliance for Access to Safe Medicines
• GLEN HODGSON, Head of Healthcare, GS1
• SULTAN DAJANI, Pharmacist Superintendent, Wainwrights Chemists
• KASPER ERNEST, Secretary General, Affordable Medicines Europe
• GEORGES FRANCE, Former VP Global LOC Quality Lead, Individual Consultant
• LINCOLN TSANG, Partner, Arnold & Porter
• PETER PITTS, President & Co-founder (Former FDA’s Associate Commissioner for External Relations), Center for Medicine in the Public Interest
• WAYNE WINEGARDEN, Sr Fellow & Director Center for Medical Economics & Innovation, Pacific Research Institute
• MERIEM LOUDIYI, Head of Unit – IP Legal Counsel, Trademarks & Fight against Falsification Dept, Servier
KEY THEMES:

• How pharma is fighting counterfeit drugs during this pandemic?
• Market analysis – EU, US and RoW markets & Impact of BREXIT
• Discuss your serialization, track and trace, and brand protection programs with industry’s top best individuals
• Track & Trace: Turning total compliance into a supply chain value plan
• Fight the FAKE – Protect the public
• IP - Cybercrime in the pharmaceutical industry: a booming business
• Technology Impact - Current digital world - Counterfeiting Technologies
• Fighting counterfeit at the world’s largest fraud market
• Choose a Serialisation solution wisely to ensure timely and lasting compliance
• Smart Packaging and Labeling - Warehouse & Logistics – Lessons to learn
• Maximizing brand protection through effective packaging and labeling
• How counterfeit medicines penetrate the legitimate supply chain
• Discover the innovative role block-chain has to play in supply chain security
• EU and USA: government policies & strategies - Comparing with RoW
• Getting ready - regulations
• Assess the current technology landscape and identify the right solution for your needs
• How can companies and gov work closely and together and its importance
• Network in our combined exhibition and catering area
• Evening networking reception for all attendees

WHO SHOULD ATTEND:

Pharmaceutical manufacturers and distributors, Healthcare professionals, Pharmacists, Serialisation, Track and Trace – Solution providers, Brand – protection, enforcement, security, integrity and management companies Drug regulatory agencies, customs and police, Intergovernmental organizations (IGOs) involved in healthcare and IPR protection, Non-governmental organizations (NGOs) active in healthcare, Patients’ representatives, Healthcare research organizations, Pharmaceutical associations, Anti-counterfeiting organizations, Packaging, labeling and converting companies, Authentication technology suppliers, Anti-counterfeiting service suppliers – IP specialists, investigators, lawyers

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading companies showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.

<< less

9th Annual Pharma AntiCounterfeiting & Serialisation 2021
“Competences to Combat Counterfeits & Impact of AI, IoT, Blockchain & Big Data in Pharma”
03rd - 04th March 2021, Virtual Conference (Time Zone – GMT)

This conference overviews and integrates the business and technical problems that more >>

4th Annual Pharma AI, IoT & Blockchain 2021
Integrating AI, IoT, Blockchain & Big Data in Pharma & Healthcare
11th March 2021, Virtual Conference (TimeZone – GMT)
This conference will provide insight into the current state of play in the EU & US and stimulate debate, in a multi-stakeholder setting, on the vital role of technology impact in the sustainability of pharma and healthcare systems. Beyond a comprehensive outlook of key European market access policies, our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions.
DELEGATE REGISTRATION:
Email: kavitha@virtueinsight.co.in or Call: +44-20 3509 3779
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
Early Bird Pricing
1 Delegate @ £300 + VAT (Valid Till 5th February 2021)
3 Delegates @ £800 + VAT (Valid Till 5th February 2021)
Standard Pricing
1 Delegate @ £450 + VAT (Valid From 6th February 2021)
3 Delegates @ £1100 + VAT (Valid From 6th February 2021)
Conference Sponsor, Exhibition Stall (Booth) & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in
KEY SPEAKERS:
• STEVEN ABRAHAMSON, Sr. Director, Region Information Security Officer, GE Healthcare (USA)
• IGNACIO QUILES LARA, VP Commercial & BUH | Spain OncoHematology, GSK
• DISA LEE CHOUN, Director Head of GCSO Innovation, UCB
• VLADIMIR ANISIMOV, Principal Data Scientist | Data Sciences | Center for Design & Analysis, Amgen
• EVI MATHIOU, Legal, Compliance & Quality Manager BA Europe East & South, Novo Nordisk
• ANDREW BRYANT, Principal Engineer / Principal Fellow, Novartis
• MYLES FURNACE, Global Digital Health Lead Partnerships Strategy, Transformation and Digital, Ipsen
• KEVIN HUA, Senior Manager A.I./Machine Learning Development, Bayer LifeScience iHub
• JON LEE-DAVEY, Global IoT Healthcare , Lead, Vodafone
• EVGENY TILEZHINSKY, Global Expansion Business Partner, Office of Business Intergity & Ethics, Vertex Pharmaceuticals
• EVGENY TILEZHINSKY, Global Expansion Business Partner, Office of Business Intergity & Ethics, Vertex Pharmaceuticals
• MARCELO O GARCIA, Former Medical Systems Head, Global Medical Affairs, Novartis
• PETER RUTHERFORD, Global Medical Lead - Orphan Renal Diseases, Vifor Pharma
• STEFANIA ALVINO, Digital & MultiChannel Manager, Daiichi Sankyo
• GABOR PURMAN, Scientific Solutions Director, NexGen Healthcare Communications
• BILL ARONSON, COO, Artificial Intelligence Research Group
• MARK DUMAN, Director, MD Healthcare
• RAMINDERPAL SINGH, CEO, Anduril
• INGO BAUMANN, Partner, Thescon
KEY THEMES DISCUSSED IN THIS CONFERENCE:
• Market overview and analysis - Shaping the future of AI in Pharma
• ML in Pharma and Medicine - A potential future in which synchronicity of data, analysis, and innovation are an everyday reality
• Applications of Machine Learning in Pharma and Medicine
• AI - Challenges and opportunities – Moving forward with a successful strategy
• Impact of Digital Transformation in healthcare & pharma industry
• Big data to big impact: AI-driven patient health optimisation
• Big data to big impact: Big data transforming the pharma industry
• Why Big Pharma Is Betting on Blockchain
• How AI technology can accelerate, cheapen and De-Risk R&D
• How IoT is transforming the Pharmaceutical Industry?
• IoT in Pharmaceutical manufacturing and supply chains
• Big Data Analytics – A Revolution in Drug Discovery and Pharma R&D
• Differences that Internet of Things (IoT) Can Make to Healthcare
• How IoT is poised to transform the world of pharma
• Developing regulatory framework in advanced and developing markets – for Today Tomorrow
• Moving beyond 5 years – What will the technology landscape look like?
• Be part of a major virtual networking opportunity
WHO SHOULD ATTEND:
CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, Evangelists and Senior Scientists from the following areas:
Pharmaceuticals, Biotech, Artificial Intelligence, Data Science, Machine Learning, IoT, Cloud, Advanced Analytics, Innovation, Big Data, Deep Learning, Bioinformatics , Regulatory Compliance, New Product Development, Process Science, Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs, Commercial Affairs, Marketing
By attending this conference, you will gain a comprehensive outlook on the key issues surrounding latest technologies that are being analysed towards the pharma and healthcare. Expand your knowledge of the latest business models and strategies in the high-level conference.
<< less

4th Annual Pharma AI, IoT & Blockchain 2021
Integrating AI, IoT, Blockchain & Big Data in Pharma & Healthcare
11th March 2021, Virtual Conference (TimeZone – GMT)
This conference will provide insight into the current state of play in the EU & US and stimulate debate, in a multi-stakeholder more >>

4th Annual Pharma Regulatory Summit 2021
18th March 2021, Virtual Conference (Time Zone - IST)

Greetings from Virtue Insight,
Join 4th Annual Pharma Regulatory Summit 2021 virtual conference and engage in a series of strategic discussions on current regulatory landscape, globalization, and harmonization initiatives in India. Virtue Insight brings you an interactive dynamics, where you will be engaged in discussions with key stakeholders influencing the advancement and implementation of regulatory convergence initiatives. Join us to discuss multi-regional cooperation, global harmonization, and best practices related to India’s regulatory landscape. Sessions will highlight regulatory approaches and good practices to ensure certainty in India and strategic initiatives to improve collaboration and cooperation.
DELEGATE REGISTRATION:
E-mail - kavitha@virtueinsight.co.in or Call M: +91 9940791115
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer.
• Early Bird Price (Till 2nd February 2021) – (INR 6,000 + GST (18%) per delegate)
• Standard Price (From 3rd February 2021) – (INR 8,000 + GST (18%) per delegate)
• For more than 5 delegates please let us know your interests.
Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in
KEY SPEAKERS:
• RAJENDRA SANGHAVI, Sr. Consulting Clinician / Expert - MedicoMarketing & TechnoLegal (Healthcare) / Chairman - Nutraceutical Committee, (IDMA)
• SADHNA JOGLEKAR, Senior Vice President, Global Medical Affairs, Sun pharma
• YASMIN SHENOY, Director-Regulatory Affairs, Sanofi-aventis
• RAHUL GUPTA, Vice President, Regulatory Affairs, USV
• PRATIK SHAH, Vice President - Medical Affairs, Bharat Serums and Vaccines
• RASHMI HEGDE, Vice President Medical, Cipla
• DEEPA ARORA, Director, CLINEXEL Life Sciences
• MILIND NARVEKAR, Vice President Global Regulatory Affairs, Teva Pharmaceuticals
• SHARADD JAIN, Vice President, Cipla
• ASHISH GAWDE, Country Medical Director, Bayer Pharmaceuticals
• AMEY MANE, Director-Medical Affairs, Dr. Reddy’s Laboratories
• SHIRAZ KANDAWALLA, Associate Director - Regulatory Affairs, Abbott
• DILIP PAWAR, Global Head Medical Affairs and Pharmacovigilance, Unichem Laboratories
• ARIF KHAN, Head – Regulatory Affairs, Pharmacovigilance and Medical Information, UCB
• SANDEEP ARORA, Medical Affairs Head, Takeda
• NANDAN JOSHI, Head Medical Affairs - Nutrition, India and Emerging Markets, Dr. Reddy's Laboratories
• HARSHAD KOTHAWADE, Head of Regulatory Management & Trade Compliance, Merck group
• MINOO BIJU, Head-Regulatory Affairs, Piramal Pharma Solutions
• SANJEEV KUMAR, Head- Regulatory External Manufacturing, Sanofi
• AMITA BHAVE, Head Regulatory Affairs GDD India, Novartis
• MANISH MAHAJAN, Head- Medical Affairs, Cadila Healthcare (BU- Biologics)
• SOFI JOSEPH, Head of Regulatory Affairs and Pharmacovigilance, Serdia Pharmaceuticals
• VARSHA NARAYANAN, Founder-Director & Senior Consultant Medical Affairs, Dr Varsha’s Health Solutions
• VISHWAS SOVANI, Founder Director, Pharmawisdom
Plus more joining soon

KEY THEMES DISCUSSED:

• Assure access to medications: How will regulatory weaknesses in pharmaceuticals be addressed?
• Political landscape: how could medical policy be affected?
• Addressing political mechanisms and advantages intended to regulate the business.
• Present regulatory system for the growth and effective production of medicinal products in scientific and technological ways
• Discussing how to ensure operational performance in compliance with the aim of better regulation.
• Regulatory and consumer opportunities for patients to approve and retain critical drugs
• Addressing existing problems in the growth of more complex off-patent medicinal products
• Regulatory structure for complex off-patent drugs, from the viewpoint of global product growth
• Regulatory challenges for medical devices
• Discussing the efficiency of the devices and regulatory initiatives
• Priorities of new Indian Commission's policies relevant to pharmaceuticals
• Addressing the Indian System of Medicine's acceptance of the new medical science by health personnel.
• Real word evidence: How it could be used to facilitate regulatory decision-making
• Addressing patient's health and health care delivery data that are regularly obtained from a number of sources
• Possible legislative options to help minimise the risk of shortages and to reduce them
• Addressing the problem as well as other supply chain issues
• Initiatives of regulatory convergence – How the regulators and stakeholders of medical products may benefit from the guidance and convergence activities in India.
• Guidelines for national regulatory authorities for medical products
• Be part of a major networking opportunity

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition.


<< less

4th Annual Pharma Regulatory Summit 2021
18th March 2021, Virtual Conference (Time Zone - IST)

Greetings from Virtue Insight,
Join 4th Annual Pharma Regulatory Summit 2021 virtual conference and engage in a series of strategic discussions on current regulatory landscape, globalization, more >>

In accordance with current government guidelines on the COVID-19 pandemic, the third CRISPR in Drug Discovery: From Targets to Therapeutics meeting will be held on 23rd and 24th March 2021 as a virtual event. Genome Engineering, including zinc-finger nucleases, TALENs and most recently CRISPR/Cas9, has become a powerful tool in the drug discovery pipeline. This meeting will focus on the application of genome engineering to identify novel drug targets through large scale CRISPR based functional genomics studies, developing advanced cellular and in vivo disease models for target validation, and the pioneering applications in therapeutic genome editing. A current perspective of the applications of these rapidly developing technologies with a focus on drug discovery applications will be the meeting’s focus. The scientific program for this CRISPR in Drug Discovery meeting will include:

Large-scale CRISPR functional genomics studies for drug target identification and validation
Application of genome engineering in developing biological models of disease from single cells through to complex in vitro tissue systems and in vivo models
Cutting edge CRISPR genome engineering technologies and their emerging applications
A perspective from technology leaders toward the future therapeutic applications of genome engineering
We aim to bring together the research community working in the field of genome engineering with interests in developing and applying the technology for pharmaceutical research. Join scientists from academia, pharma, biotech and CRO’s online to hear talks given by speakers at the cutting edge of genome engineering, network at the virtual exhibition and gain strategic insights into solutions for increasing the success of drug discovery and development. << less

In accordance with current government guidelines on the COVID-19 pandemic, the third CRISPR in Drug Discovery: From Targets to Therapeutics meeting will be held on 23rd and 24th March 2021 as a virtual event. Genome Engineering, including zinc-finger nucleases, TALENs and most recently CRISPR/Cas9, more >>

On behalf of the "8th World Congress on Epigenetics and chromosome" Conference we tend to square measure glad invite all the medical professionals within the field of Epigenetics and Chromosome to hitch the webinar scheduled on May 17-18, 2021 The principal objective of this conference is to produce a global platform for leading edge analysis in chromosome and Epigenetics.

The encompassing goal of this conference is to cover chromatin and chromosome Dynamics, Cytogenetics, sign to chromosome, Nuclear design and Dynamics, biological process Epigenetics, Epigenetics and Human Diseases, Genome Stability, Environmental Epigenetics, Tran’s people Inheritance, genomics, System Biology and Super Resolution research.

Conference has Associate in Nursing increased options of scientific partnerships and alliances with development agencies, Institutes, leading analysis organizations, non-government organizations, and different entities to market the development-oriented analysis across the globe through live streaming. Our aim is to provide cancer surgeons, oncologist researchers, students industrial Deligates and professionally involved in study of Epigenetics. << less

On behalf of the "8th World Congress on Epigenetics and chromosome" Conference we tend to square measure glad invite all the medical professionals within the field of Epigenetics and Chromosome to hitch the webinar scheduled on May 17-18, 2021 The principal objective of this conference is to produce more >>

18th of May 2021 at the AstraZeneca R&D site in Gothenburg. This interactive 2-day conference will host world leading scientists from academia and industry to discuss current and future perspectives of Cell and Gene Therapies.

Cell and gene therapies are rapidly evolving at a fast pace, revealing many new and exciting therapeutic opportunities not previously amenable to drug discovery. We aim to bring together scientists from academia, pharma, biotech, and CRO’s to engage with speakers at the cutting edge of developing and applying cell and gene therapies.

The event will help participants develop a better understanding of the field and provide networking opportunities with a range of key experts. Our aim is to create an open and inspiring environment that will foster discussions and the identification of opportunities for collaboration with a scientific program developed around three key focus areas:

• Cell based therapies across disease areas
• Recent advances in cancer gene therapies
• Therapies for genetic conditions

There will be numerous opportunities to network with scientists and researchers from the pharmaceutical, academic and vendor communities throughout the 2-day conference. The program also includes poster viewing sessions, a poster spotlight presentation opportunity for select posters, vendor exhibition, speaker’s dinner and tour of the Amazing Journey at AstraZeneca. << less

18th of May 2021 at the AstraZeneca R&D site in Gothenburg. This interactive 2-day conference will host world leading scientists from academia and industry to discuss current and future perspectives of Cell and Gene Therapies.

Cell and gene therapies are rapidly evolving at a fast pace, revealing more >>

Euro Optics 2021 Scientific committee is visiting be delighted to welcome individuals from all around the world to maneuver to the 14th International Conference on Optics, Photonics & Laser (Webinar) on MAY 24-25,2021
Theme : Explore the Standardized Development of Optics, Photonics & Laser

The global need for effective medicines is increasing, whilst the biology underlying new drug concepts is becoming increasingly complex. This meeting will outline how our research community is rising to address these challenges by following the early life cycle of new medicine concepts through 3 critical stages: 1) Identifying your target. 2) Drugging your target. 3) Gaining clinical insights. These session themes will run sequentially and blend the most exciting science from early career researchers, commercial organisations and key academic, clinical and industry leaders in the field. In addition, an interactive panel discussion will provide the opportunity to share perspectives on some of the most current and innovative routes though which to translate scientific ideas into impactful therapies. Topics in scope for this scientific program will include:
Target Identification & Validation
• Disease-centric biology insights & dealing with increasingly complex target biology
• Leveraging emerging platform technologies
• Deconvoluting target hit lists
Drugging your target
• How new drug formats are changing drug discovery
• New concepts in pharmacology – poly-pharmacology, cellular kinetics etc
• New models of collaborative drug discovery (panel discussion topic)
Clinical insights
• Experimental medicine studies with proprietary and/or essential medicines
• Examples of successful clinical translation of new medicine concepts
• Bringing patient data insights into the discovery pipeline
Through this meeting, we aim to bring together the research community working in the field of new medicine creation with interests in developing their translational research ideas and applying novel technologies and means of collaboration to address critical clinical needs. Join scientists from academia, pharma, biotech and CRO’s either in person or online to hear talks given by speakers at the cutting edge of their field and gain strategic insights into solutions for increasing the success of your therapeutic ideas.
<< less

The global need for effective medicines is increasing, whilst the biology underlying new drug concepts is becoming increasingly complex. This meeting will outline how our research community is rising to address these challenges by following the early life cycle of new medicine concepts through 3 critical more >>

A Hybrid Experience: In-person and Online Presentations & Sessions
This meeting annually attracts 700-1,100 of the world’s leading immunology experts and covers both fundamental and clinical research specific to the role of cytokines in health and disease. Many of the major advances in cytokine biology were first reported at this annual conference, and we very much look forward to continuing this strong tradition this October at the Cardiff City Hall in Cardiff, Wales.

Cytokines 2021 will combine the physical event at the Cardiff City Hall in the Centre of Cardiff, with the LabRoots Virtual Meeting platform for a unique experience bringing both the in-person and virtual community together. Online presentations will be intertwined with physical presentations and sessions including virtual interactions, live commentary, online chat & video chats, webcast video presentation and discussion. << less

A Hybrid Experience: In-person and Online Presentations & Sessions
This meeting annually attracts 700-1,100 of the world’s leading immunology experts and covers both fundamental and clinical research specific to the role of cytokines in health and disease. Many of the major advances in cytokine biology more >>

Drug Discovery 2021

The fourth ELRIG meeting on Advances in Cell Based Profiling in Drug Discovery will be held on the 9th and 10th of November 2021 at the AstraZeneca R&D premises in Gothenburg. This interactive 2-day event will host leading scientists from academia and industry to discuss current and future formats for cell based assays. Following on from our last meeting in 2019 this bi-annual meeting will also this time be accompanied by a satellite meeting on Chemical Biology on November 11th, organized by key academic infrastructures in the Nordic countries. Our aim is to create an open and inspiring environment for networking between biologists and chemists, working towards a common view on expectations from our cell assays and their use for target identification, target validation and compound profiling purposes. << less

The fourth ELRIG meeting on Advances in Cell Based Profiling in Drug Discovery will be held on the 9th and 10th of November 2021 at the AstraZeneca R&D premises in Gothenburg. This interactive 2-day event will host leading scientists from academia and industry to discuss current and future formats for more >>

Pharmaceutical Flow Cytometry & Imaging 2021
The 7th biennial Pharmaceutical Flow Cytometry and Imaging meeting will be held at GlaxoSmithKline, Stevenage, UK. Flow cytometry and imaging are two powerful technology platforms that enable high-content analysis of physiologically-relevant cell systems and pre-clinical and clinical biomarkers. Since our first meeting in 2008, we have seen the technology develop and the applications widen across many areas of industrial and academic drug discovery and development.
This meeting will focus on the application of Flow Cytometry and Imaging to illuminate biology from the single cell to the patient. The scientific program for this meeting is:
Translational Flow Cytometry and Imaging in Drug Discovery and Development: Application of technology in biological models from the microscale and single cell through to complex in-vitro tissue systems and the clinic.
Novel and Emerging Technologies: Next generation instrumentation, and probe and sensor technology for pharmaceutical research.
Drug discovery in the era of Multi-omics and spatial cytometry: Exploration of the latest multi-parameter techniques and the analytical challenges of using multi-omics approaches to link the genome and proteome to cellular regulation and function.
We aim to bring together the research community working in the field of flow cytometry and imaging with interests in developing and applying the technology for pharmaceutical research. Join scientists from pharma, biotech, CROs and academia to hear talks given by speakers at the cutting edge of cytometry, take part in commercial vendor lab-based workshops, network at the exhibition, innovation forum and speakers dinner and gain strategic insights into solutions for increasing the success of drug discovery and development.
<< less

Pharmaceutical Flow Cytometry & Imaging 2021
The 7th biennial Pharmaceutical Flow Cytometry and Imaging meeting will be held at GlaxoSmithKline, Stevenage, UK. Flow cytometry and imaging are two powerful technology platforms that enable high-content analysis of physiologically-relevant cell systems more >>